MOGGI PIGNONE, ALBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.345
EU - Europa 9.033
AS - Asia 7.089
SA - Sud America 847
AF - Africa 246
Continente sconosciuto - Info sul continente non disponibili 218
OC - Oceania 126
Totale 31.904
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 14.075
RU - Federazione Russa 3.264
IT - Italia 2.113
SG - Singapore 2.110
CN - Cina 1.681
HK - Hong Kong 1.033
PL - Polonia 827
VN - Vietnam 772
IE - Irlanda 731
BR - Brasile 666
KR - Corea 596
SE - Svezia 581
DE - Germania 352
FR - Francia 319
FI - Finlandia 295
IN - India 200
CA - Canada 177
GB - Regno Unito 176
UA - Ucraina 170
BD - Bangladesh 156
AU - Australia 121
TR - Turchia 102
JO - Giordania 92
JP - Giappone 90
AR - Argentina 68
ID - Indonesia 65
CI - Costa d'Avorio 44
IQ - Iraq 42
NL - Olanda 38
ES - Italia 35
MX - Messico 35
ZA - Sudafrica 33
EC - Ecuador 30
MA - Marocco 27
CH - Svizzera 25
NG - Nigeria 23
CO - Colombia 22
EG - Egitto 22
VE - Venezuela 20
BJ - Benin 19
PK - Pakistan 18
TN - Tunisia 18
PY - Paraguay 17
AT - Austria 16
BE - Belgio 16
KE - Kenya 16
JM - Giamaica 15
PH - Filippine 15
TH - Thailandia 14
SA - Arabia Saudita 12
UZ - Uzbekistan 12
LT - Lituania 9
CL - Cile 8
CZ - Repubblica Ceca 8
NP - Nepal 8
PE - Perù 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
DZ - Algeria 7
KZ - Kazakistan 7
MY - Malesia 7
TT - Trinidad e Tobago 7
HU - Ungheria 6
IL - Israele 6
SC - Seychelles 6
SD - Sudan 6
CM - Camerun 5
CR - Costa Rica 5
HN - Honduras 5
LB - Libano 5
LV - Lettonia 5
NZ - Nuova Zelanda 5
PT - Portogallo 5
RO - Romania 5
TW - Taiwan 5
UY - Uruguay 5
AZ - Azerbaigian 4
ET - Etiopia 4
GT - Guatemala 4
KG - Kirghizistan 4
NI - Nicaragua 4
NO - Norvegia 4
PA - Panama 4
BG - Bulgaria 3
BO - Bolivia 3
BW - Botswana 3
BY - Bielorussia 3
GE - Georgia 3
HR - Croazia 3
KH - Cambogia 3
KW - Kuwait 3
LA - Repubblica Popolare Democratica del Laos 3
MD - Moldavia 3
OM - Oman 3
PR - Porto Rico 3
PS - Palestinian Territory 3
SV - El Salvador 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
Totale 31.649
Salva come PNG Salva come JPEG
Città #
Santa Clara 2.713
Ashburn 1.796
Singapore 1.505
Fairfield 1.112
Hong Kong 846
Warsaw 822
Chandler 798
Dublin 723
Seoul 589
San Jose 496
Woodbridge 491
Seattle 446
Cambridge 439
Milan 404
Beijing 386
Wilmington 370
Houston 366
Hefei 306
Jacksonville 272
Ho Chi Minh City 271
Florence 268
Buffalo 228
Los Angeles 215
Princeton 195
Rome 192
Lauterbourg 191
The Dalles 182
Ann Arbor 181
Altamura 165
Hanoi 165
Lawrence 164
Moscow 147
Boston 135
Dallas 133
Boardman 129
Munich 129
Melbourne 116
Medford 112
New York 111
Mumbai 95
Helsinki 89
São Paulo 85
Tokyo 85
Paris 79
San Diego 75
Izmir 67
Shanghai 67
Naples 63
Kent 59
Council Bluffs 58
Turin 53
Abidjan 44
Turku 44
Toronto 43
Falls Church 40
Bologna 39
Chicago 39
Jakarta 39
Frankfurt am Main 38
Dong Ket 37
Da Nang 36
Palermo 36
Redondo Beach 35
Orem 34
Montreal 33
Norwalk 33
Yubileyny 33
Guangzhou 28
London 28
Pune 26
Figino 25
Atlanta 23
Bari 22
Phoenix 22
Abuja 21
Andover 20
Denver 20
Genoa 20
Brooklyn 19
Catania 19
Chennai 19
Clifton 19
Cotonou 19
Hillsboro 19
Johannesburg 19
Baghdad 18
Haiphong 18
Belo Horizonte 17
Poplar 17
Biên Hòa 16
San Francisco 16
Shenzhen 16
Verona 16
Cagliari 15
Mexico City 15
Miano 15
Brussels 14
Columbus 14
Philadelphia 14
Bengaluru 13
Totale 20.409
Salva come PNG Salva come JPEG
Nome #
Effect of N-acetyl-L-cysteine on peroxynitrite and superoxide anion production of lung alveolar macrophages in systemic sclerosis 341
The fibrinolytic system components are increased in systemic sclerosis and modulated by Alprostadil (alpha1 ciclodestryn). 331
[Peripheral nervous system in limited systemic sclerosis]. 331
Doppler ultrasound unveils splanchnic arteries ischemia allowing early successful revascularization in symptomatic systemic sclerosis patients 290
Assessment, definition, and classification of lower limb ulcers in systemic sclerosis: A challenge for the rheumatologist 249
Left atrial dysfunction detected by speckle tracking in patients with systemic sclerosis. 247
The challenge of pet therapy in systemic sclerosis: evidence for an impact on pain, anxiety, neuroticism and social interaction 243
Lack of activation of renal functional reserve predicts the risk of significant renal involvement in systemic sclerosis. 241
Use of vasoactive/vasodilating drugs for systemic sclerosis (SSc)-related digital ulcers (DUs) in expert tertiary centres: results from the analysis of the observational real-life DeSScipher study 240
Usefulness of procalcitonin in differentiating Candida and bacterial blood stream infections in critically ill septic patients outside the intensive care unit 240
18F-fluorodeoxyglucose positron-emission tomography/CT and lung involvement in systemic sclerosis 237
Biohumoral markers as predictor of right ventricular dysfunction in AL Amyloidosis. 235
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline 224
A rare case of Candida glabrata spondylodiscitis: case report and literature review 211
Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers 208
IL CONTRIBUTO DELLA TELEMEDICINA ALLA GESTIONE DEI PAZIENTI REUMATOLOGICI DURANTE LA PANDEMIA DA SARS-CoV-2 207
Prophylactic activity of increasing doses of intravenous histamine in refractory migraine: Retrospective observations of a series of patients with migraine without aura 207
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: the Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 206
Acute heart failure in the elderly: setting related differences in clinical features and management 206
Intravenous immunoglobulins improve the function and ameliorate joint involvement in systemic sclerosis: a pilot study. 202
Liver dysfunction as predictor of prognosis in patients with amyloidosis: utility of the Model for End-stage Liver disease (MELD) scoring system 199
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis. 198
The Renal Resistive Index in systemic sclerosis: Determinants, prognostic implication and proposal for specific age-adjusted cut-offs 198
The platypnea-orthodeoxia syndrome: an unusual case of dyspnea 197
Echocardiographic and biohumoral characteristics in patients with AL and TTR amyloidosis at diagnosis 195
Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis. 192
Use of the FebriDx point-of-care test for the exclusion of SARS-CoV-2 diagnosis in a population with acute respiratory infection during the second (COVID-19) wave in Italy 191
Pregnancy in systemic sclerosis (SSc): results of systematic review and meta-analysis 190
Enthesopathy and involvement of synovio-entheseal complex in systemic sclerosis: an ultrasound pilot study 190
Letter to Habets JGV et al. on “A rare case of Candida glabrata spondylodiscitis: case report and literature review” 188
Damage of cutaneous peripheral nervous system evolves differently according to the disease phase and subset of systemic sclerosis 187
HFmrEF in elderly patients hospitalised for acute heart failure: data from the ATHENA registry 187
The role of chest CT in deciphering interstitial lung involvement: systemic sclerosis versus COVID-19 186
Accuracy of lung ultrasound performed with handheld ultrasound device in internal medicine: an observational study 185
Switching from originator adalimumab to biosimilar SB5 in a rheumatology cohort: persistence on treatment, predictors of drug interruption and safety analysis 185
Exercise Stress Echocardiography of the Right Ventricle and Pulmonary Circulation 183
Oxidative stress in Systemic Sclerosis. 183
Dimensions of psychological dysfunction in patients with fibromyalgia: development of an Italian questionnaire. 182
Systemic amyloidosis: a challenge for the rheumatologist. 179
Incidence and characteristics of asymptomatic distal deep vein thrombosis unexpectedly found at admission in an Internal Medicine setting 179
A case of persistent hiccup after laparoscopic cholecystectomy. 179
Therapeutic challenges for systemic sclerosis: facts and future targets. 178
Amyloidoses 178
THE EXPERIENCE OF A RHEUMATOLOGY UNIT DURING THE COVID19 LOCKDOWN: TELEMEDICINE ALLOWS A SAFE FOLLOW UP OF PATIENTS WITH RHEUMATIC DISEASES 175
Digital ulcers in scleroderma: staging, characteristics and sub-setting through observation of 1614 digital lesions. 175
The safety of iloprost in systemic sclerosis in a real-life experience 174
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 174
Renal functional reserve is impaired in patients with systemic sclerosis without clinical signs of kidney involvement. 173
Dural metastasis without subdural hematoma or subdural fluid collection in a patient with signet ring cell gastric adenocarcinoma 172
Angiotensin-converting enzyme I/D polymorphism and macrovascular disease in systemic sclerosis 172
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis-Interstitial Lung Disease in the European Scleroderma Trial and Research Database 171
Are disease-related pulmonary perfusion abnormalities detectable in COVID-19 patients? Suspicious findings in a lung perfusion SPECT performed for ruling out classical pulmonary embolism 171
Circulating levels of Nepsilon-(carboxymethyl)lysine are increased in systemic sclerosis. 171
Therapeutic challenges for systemic sclerosis: facts and future targets. 171
The classification of hospitalized patients with hyperglycemia and its implication on outcome: results from a prospective observational study in Internal Medicine 169
Bcl-2, p53 and c-myc expression in juvenile dermatomyositis. 168
The doctor who stared at schistocytes: an intriguing case of suspected thrombotic microangiopathic anemia 168
Acute heart failure in the elderly: real world evidence from the ATHENA registry 167
Piascledine modulates the production of VEGF and TIMP-1 and reduces the invasiveness of rheumatoid arthritis synoviocytes. 165
EULAR EVIDENCE BASED RECOMMENDATIONS FOR THE DIAGNOSIS AND MANAGMENT OF GOUT 164
Valutazione circadiana dell’ attività fibrinolitica circolante nella Sclerosi Sistemica. 164
Angiotensin converting enzyme a new tool for the follow-up of endothelial injury in paediatric vasculitides. 163
Effect of melatonin on normal and sclerodermic skin fibroblast proliferation. 163
Discrepant expression of neprilysin on fibroblasts in diffuse systemic sclerosis. 163
Deflazacort modulates the fibrinolytic pattern and reduces uPA-dependent chemioinvasion and proliferation in rheumatoid arthritis synoviocytes. 163
Cardiorenal end points in a trial of aliskiren for type 2 diabetes. 162
HFrEF, HFmrEF and HFpEF: which is the treatment of choice at discharge? Real world data from the ATHENA registry 162
ULTRASOUND (US) EVALUATION OF BOWEL VASCULOPATHY IN SYSTEMIC SCLEROSIS (SSC) 161
Current Treatment Options in Raynaud's Phenomenon. 161
Acute heart failure in the real world: are elderly patients managed in accordance to current guidelines? Data from the ATHENA registry 160
A Multinational Survey Investigating the Unmet Needs and Patient Perspectives Concerning Proton Pump Inhibitors in Systemic Sclerosis   159
[Patterns of ventricular late potentials in systemic sclerosis: a noninvasive method in the study of cardiac involvement]. 158
HFmrEF in elderly patients: the pathogenetic role of ischemia. Real world data from the ATHENA registry 157
Acute heart failure in the elderly: which are the main precipitating causes of heart failure? Real world evidence from the ATHENA registry 157
ANGIOTENSIN CONVERTING ENZYME A NEW TOOL FOR THE FOLLOW-UPOF ENDOTHELIAL INJURY IN PEDIATRIC VASCULITIDES 157
Oral lactobacillus species in systemic sclerosis 157
Lung ultrasound B-lines in systemic sclerosis: cut-off values and methodological indications for interstitial lung disease screening 157
The role of lung biopsy for diagnosis and prognosis of interstitial lung disease in systemic sclerosis: a systematic literature review 156
Central nervous system hemangiopericytoma with bone and lung metastases: a case report. 156
Pulmonary Circulation on the Crossroads Between the Left and Right Heart in Systemic Sclerosis: A Clinical Challenge for Cardiologists and Rheumatologists 156
EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT) 156
Consensus statement concerning cardiotoxicity occurring during haematopoietic stem cell transplantation in the treatment of autoimmune diseases, with special reference to systemic sclerosis and multiple sclerosis 155
Lung magnetic resonance imaging in systemic sclerosis: a new promising approach to evaluate pulmonary involvement and progression 155
The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases 154
High prevalence of polymorphisms of angiotensin-converting enzyme (I/D) and endothelial nitric oxide synthase (Glu298Asp) in patients with systemic sclerosis. 154
Melatonin is a safe and effective treatment for chronic pulmonary and extrapulmonary sarciodosis 153
Pulmonary arterial hypertension and rheumatic diseases--from diagnosis to treatment. 152
Patients' unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis 151
Urokinase-type plasminogen activator is the main plasminogen activator produced by synoviocytes of osteoarthritis and rheumatoid arthitis 151
Anti-endothelial cell antibodies in systemic sclerosis: significant association with vascular involvement and alveolo-capillary impairment. 151
Hemorheologic profile in systemic sclerosis: role of NOS3 -786T > C and 894G >T polymorphisms in modulating both the hemorheologic parameters and the susceptibility to the disease. 150
Diene-conjugates and antibodies against oxidized low-density lipoproteins in systemic sclerosis. 150
Are Angiotensin Converting Enzyme and von Willebrand factor circulating levels useful surrogate parameters to monitor disease activity in Kawasaki disease? 150
The renal resistive index: A new biomarker for the follow-up of vascular modifications in systemic sclerosis 150
Increased circulating levels of tissue kallikrein in systemic sclerosis correlate with microvascular involvement 149
POS1593-HPR GASTROINTESTINAL INVOLVEMENT IS ALREADY REPORTED IN AN ITALIAN VEDOSS COHORT: RESULTS FROM A RHEUMATOLOGICAL NURSE ASSESSMENT 148
Pulmonary arterial hypertension in systemic sclerosis: diagnostic pathway and therapeutic approach. 147
"Autoimmunity part D; Autoimmune disease, annus mirabilis" - Chapter: Exercise doppler echo cardiography identifies reclini asympthomatic pulmonary hypertension in sistemi sclerosis. 146
Cardiac amyloidosis: the heart of the matter. 146
The positive side of the coin: Sars-Cov-2 pandemic has taught us how much Telemedicine is useful as standard of care procedure in real life 146
Totale 18.311
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.544
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.544
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.215 0 107 53 68 66 116 46 69 62 64 192 372
2022/20233.088 337 542 117 266 244 576 393 157 292 24 88 52
2023/20241.333 67 137 203 59 87 207 70 242 25 90 94 52
2024/20258.702 298 872 554 1.446 2.424 995 261 422 480 262 339 349
2025/202611.032 1.207 1.415 900 725 1.221 433 1.412 540 713 649 453 1.364
2026/2027663 403 260 0 0 0 0 0 0 0 0 0 0
Totale 31.904